ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,827,109 | -12.3% | 532,087 | +6.0% | 0.00% | 0.0% |
| Q2 2023 | $6,646,638 | +1.5% | 502,012 | +4.3% | 0.00% | 0.0% |
| Q1 2023 | $6,549,662 | +71030.1% | 481,239 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $9,208 | -99.9% | 471,508 | +5.5% | 0.00% | 0.0% |
| Q3 2022 | $8,513,000 | +3.8% | 446,881 | +12.3% | 0.00% | 0.0% |
| Q2 2022 | $8,200,000 | -36.2% | 398,075 | -0.3% | 0.00% | -50.0% |
| Q1 2022 | $12,854,000 | -26.1% | 399,450 | +6.9% | 0.00% | 0.0% |
| Q4 2021 | $17,403,000 | +85.6% | 373,788 | +7.6% | 0.00% | +100.0% |
| Q3 2021 | $9,378,000 | +28.7% | 347,363 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $7,284,000 | -22.6% | 283,978 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $9,413,000 | +53.7% | 275,409 | +52.1% | 0.00% | 0.0% |
| Q4 2020 | $6,125,000 | +65.2% | 181,112 | +20.5% | 0.00% | 0.0% |
| Q3 2020 | $3,707,000 | – | 150,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |